CSL Limited Sponsored ADR (OTCMKTS:CSLLY - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $65.13 and last traded at $67.19, with a volume of 219715 shares trading hands. The stock had previously closed at $69.33.
CSL Trading Up 2.3%
The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.85 and a current ratio of 1.86. The stock's 50 day simple moving average is $80.19 and its 200-day simple moving average is $79.31.
CSL Company Profile
(
Get Free Report)
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.
Read More
Before you consider CSL, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CSL wasn't on the list.
While CSL currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
